Seeing Is Believing
ARWR is currently covered by 13 analysts with an average price target of $30.56. This is a potential upside of $19.88 (186.14%) from yesterday's end of day stock price of $10.68.
Arrowhead Pharmaceuticals's activity chart (see below) currently has 182 price targets and 177 ratings on display. The stock rating distribution of ARWR is 84.91% BUY and 15.09% HOLD.
Analysts average stock forecasts to be materialized ratio is 66.88% with an average time for these price targets to be met of 256.95 days.
Highest price target for ARWR is $80, Lowest price target is $26, average price target is $47.09.
Most recent stock forecast was given by MAYANK MAMTANI from B. RILEY on 14-Feb-2025. First documented stock forecast 18-Dec-2013.
Currently out of the existing stock ratings of ARWR, 45 are a BUY (84.91%), 8 are a HOLD (15.09%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$38
$27.32 (255.81%)
$55
1 months 22 days ago
(14-Feb-2025)
8/16 (50%)
$18.89 (98.85%)
135
Buy
$60
$49.32 (461.80%)
$60
1 months 25 days ago
(11-Feb-2025)
4/19 (21.05%)
$41.11 (217.63%)
193
Buy
$42
$31.32 (293.26%)
$42
1 months 25 days ago
(11-Feb-2025)
2/10 (20%)
$23.11 (122.34%)
100
Buy
$80
$69.32 (649.06%)
$80
2 months 13 days ago
(23-Jan-2025)
0/21 (0%)
$58.47 (271.57%)
Buy
$45
$34.32 (321.35%)
$62
4 months 9 days ago
(27-Nov-2024)
22/36 (61.11%)
$18.85 (72.08%)
154
What is ARWR (Arrowhead Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on ARWR (Arrowhead Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on ARWR (Arrowhead Pharmaceuticals)?
Which analyst is the currently most bullish on ARWR (Arrowhead Pharmaceuticals)?
Which analyst is the currently most reserved on ARWR (Arrowhead Pharmaceuticals)?